Log in

Relevant bibliographies by topics / Hybridation in situ fluorescence / Journal articles

To see the other types of publications on this topic, follow the link: Hybridation in situ fluorescence.

Journal articles on the topic 'Hybridation in situ fluorescence'

Author: Grafiati

Published: 4 June 2021

Last updated: 11 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Hybridation in situ fluorescence.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Monier, K., M. Hazzouri, F. Mongelard, S. Rousseaux, C. Vourc'h, and M. Robert-Nicoud. "Cartographie à haute résolution par hybridation in situ fluorescente sur fibres d'ADN décondensées." médecine/sciences 13, no. 11 (1997): 1306. http://dx.doi.org/10.4267/10608/550.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Robinet, Gwladys, Bénédicte Nouyou, Francisco Llamas-Gutierrez, et al. "Analyse par hybridation in situ en fluorescence (FISH) d’une série de 47 lymphomes avec le système BioView ®." Morphologie 101, no. 335 (2017): 243. http://dx.doi.org/10.1016/j.morpho.2017.07.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Vago, P., C. Goumy, J. Y. Jaffray, M. N. Bonnet-Dupeyron, and A. Geneix. "Diagnostic prénatal rapide par hybridation in situ fluorescente chez les fœtus de parents remaniés." Morphologie 90, no. 289 (2006): 82. http://dx.doi.org/10.1016/s1286-0115(06)74387-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Gnamey, D. K., J. P. Dovi-Akué, R. B. Darboux, A. Laleye, P. Adjenou, and F. Adanlete. "Hybridation in situ en fluorescence et trisomie 13 en mosaïque : un exemple de difficultés de prise en charge des maladies génétiques au Togo." Archives de Pédiatrie 8, no. 5 (2001): 555. http://dx.doi.org/10.1016/s0929-693x(00)00257-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Zini, Gina, Stefano Valentini, Pierluigi Puggioni, et al. "Detection of the BCR-ABL Fusion protein2 by Using the Abbott Cell Dyn Sapphire.a Routine Blood Hematology Analyser." Blood 114, no. 22 (2009): 4699. http://dx.doi.org/10.1182/blood.v114.22.4699.4699.

Full text

Abstract:

Abstract Abstract 4699 Objectives We have evaluated the possibility to use the new BD Cytometric Bead Array to detect the presence of the BCR-ABL fusion protein2 in peripheral blood samples with a routine blood hematology analyser, the Abbott Cell-Dyn Sapphire, for a quick identification of those positive samples, both at diagnosis and at follow up to detect the MRD. This pilot study was carried out on 5 samples with different level of BCR-ABL fusion protein2 plus 2 control samples positive and negative respectively: results were compared with those obtained with the BD FACScanto and the stand

APA, Harvard, Vancouver, ISO, and other styles

6

Akhdar, Abbas, Marc Bronsard, Renald Lemieux, and Sameh Geha. "Détermination de l’amplification de l’oncogène HER-2 dans le cancer du sein invasif par hybridation chromogénique in situ double couleur (dc-CISH) : étude comparative avec l’hybridation fluorescente in situ (FISH)." Annales de Pathologie 31, no. 6 (2011): 472–79. http://dx.doi.org/10.1016/j.annpat.2011.10.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

García-García, Y., A. Martínez-Fernández, M. Muñoz Mateu, et al. "HER2-positive breast cancer cells percentage and progression to trastuzumab treatment in metastatic patients." Journal of Clinical Oncology 25, no. 18_suppl (2007): 11510. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.11510.

Full text

Abstract:

11510 Background: Immunohistochemistry (IHC) assay for HER2 in breast cancer (BC) identify patients (pts) who are at benefit from Trastuzumab (T) therapy. The percentage (%) of positive cells is not known to have prognostic significance. Methods: We analyze pts that received T as a treatment for metastatic BC in our center, in monotherapy or in combination with other agents, and to ascertain whether the % of her-2 positive cells can be a predictive factor of response to therapy with T. We define HER-2 positive cells according to the Envision method 3+, valuating the percentage of cells with po

APA, Harvard, Vancouver, ISO, and other styles

8

Vassias, Isabelle. "Hybridation in situ." EMC - Biologie Médicale 1, no. 1 (2006): 1–4. http://dx.doi.org/10.1016/s2211-9698(06)76399-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Boffa, M. C. "Hybridation in situ." La Revue de Médecine Interne 17, no. 6 (1996): 505–7. http://dx.doi.org/10.1016/0248-8663(96)86452-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Masci, Giovanna, Michele Caruso, Agnese Losurdo, et al. "HER2 assessment and Ki-67 labeling index in a cohort of male breast cases: The Ich Network on Cancer Research (INCaRe) experience." Journal of Clinical Oncology 30, no. 15_suppl (2012): 623. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.623.

Full text

Abstract:

623 Background: The overall incidence of male breast cancers (MBC) is around 1% of all breast cancers and is on the rise.Most of our current knowledge regarding its biology and treatment strategies has been extrapolated from its female counterpart. However, from literature data, it is more and more evident that MBC has biological differences compared with female breast cancer (FBC). While hormone receptors are more frequently positive in MBC than in FBC, HER-2 seems to be less expressed in MBC than in FBC, with data ranging from 0 to 18%; no data on Ki-67 have been so far reported. Methods: We

APA, Harvard, Vancouver, ISO, and other styles

11

Loscertales, Javier, Eva Arranz, Maria-Angeles Sanz, et al. "Newly acquired chromosome Abnormalities During Course of CLL: a Retrospective Collection Data From 2 Spanish Centers." Blood 114, no. 22 (2009): 4384. http://dx.doi.org/10.1182/blood.v114.22.4384.4384.

Full text

Abstract:

Abstract Abstract 4384 Background Different recurrent cytogenetic abnormalities have shown clear prognostic value in patients with Chronic Lymphocytic Leukemia (CLL). Acquisition of cytogenetic aberrations during evolution of the disease (i.e. clonal evolution) may have clinical implications. Objective of the study To analyze the frequency of clonal evolution and its potential clinical consequences. Methods and Materials We retrospectively collect data from 80 patients diagnosed of CLL, who had been made at least two Fluorescence In Situ Hybridation (FISH) studies, with probes for gene ATM (11

APA, Harvard, Vancouver, ISO, and other styles

12

Svrcek, Magali, Raphael Colle, Anne Cayre, et al. "Prevalence of NTRK1/3 fusions in mismatch repair-deficient (dMMR)/microsatellite instable (MSI) tumors of patients with metastatic colorectal cancer (mCRC)." Journal of Clinical Oncology 39, no. 15_suppl (2021): e15537-e15537. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e15537.

Full text

Abstract:

e15537 Background: Inhibitors of tropomyosin receptor kinase (TRK) have shown promising activity against neurotrophic TRK ( NTRK) fusion-driven cancers, regardless of tumor histotype or cell of origin. NTRK gene fusions are observed in less than 1% of colorectal cancers (CRCs). CRCs harboring wild-type BRAF and KRAS and MisMatch Repair deficiency (dMMR)/MicroSatellite Instability (MSI) due to MLH1 hypermethylation have been associated with NTRK fusions in small cohorts of non-metastatic tumors. We aimed at evaluating the incidence of NTRK fusions among dMMR/MSI metastatic CRCs (mCRC) for which

APA, Harvard, Vancouver, ISO, and other styles

13

Le Novère, Nicolas. "Approches théoriques et pratiques en hybridation in situ et autoradiographie réceptorielle." Annales de l'Institut Pasteur / Actualités 9, no. 3 (1998): 259–70. http://dx.doi.org/10.1016/s0924-4204(99)80005-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Gas, N., M. C. Azum, J. Noaillac-Depeyre, and M. A. Dupont. "Localisation des genes ribosomiques par hybridation in situ a l'aide d'une sonde sulfonee." Biology of the Cell 63, S1 (1988): 11–11. http://dx.doi.org/10.1016/0248-4900(88)90157-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Rivero, Gustavo A., Dangayach Priti, Jun Zhang, and Marylin Li. "Acute Differentiation Syndrome Is a Biological Consequence Of Treatment With Azanucleoside In Isocitrate Dehydrogenase-1 (IDH-1) and SFR2 mutated Myelodysplasia Derived Acute Myelogenous Leukemia." Blood 122, no. 21 (2013): 4982. http://dx.doi.org/10.1182/blood.v122.21.4982.4982.

Full text

Abstract:

Abstract Background Treatment related toxicity complicates outcome in elderly patients with AML (Estey et al. Blood. 2006). Conventionally, 7+3 induction (anthracycline plus cytarabine) results in Complete Remission rate of about 30%. Regimens with less toxicity, such as 10-days (d) schedule of DAC, seem promising with CR rate of 47% (Blum et al. PNAS. 2010). In secondary MDS derived AML, response prediction could be derived from mutation status in epigenetic modifiers (IDH1, IDH2, DNMT3 A, TET2), transcriptional regulators (RUNX1, CBL), and genes in spliceosome machinery, such as SF3B1 and SR

APA, Harvard, Vancouver, ISO, and other styles

16

VINAS, P., I. LOPEZGARCIA, B. MERINOMERONO, and M. HERNANDEZCORDOBA. "Liquid chromatography–hydride generation–atomic fluorescence spectrometry hybridation for antimony speciation in environmental samples." Talanta 68, no. 4 (2006): 1401–5. http://dx.doi.org/10.1016/j.talanta.2005.07.056.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Amare, P. S., C. Baisane, T. Saikia, R. Nair, H. Gawade, and S. Advani. "Fluorescence in situ hybridization." Cancer Genetics and Cytogenetics 131, no. 2 (2001): 125–34. http://dx.doi.org/10.1016/s0165-4608(01)00504-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Price, C. M. "Fluorescence in situ hybridization." Blood Reviews 7, no. 2 (1993): 127–34. http://dx.doi.org/10.1016/s0268-960x(05)80023-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Uzumori, K. "Fluorescence in situ hybridization." International Journal of Gynecology & Obstetrics 70 (2000): D2. http://dx.doi.org/10.1016/s0020-7292(00)82484-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Chen, Amy Y. Y., and Andrew Chen. "Fluorescence In Situ Hybridization." Journal of Investigative Dermatology 133, no. 5 (2013): 1–4. http://dx.doi.org/10.1038/jid.2013.120.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Tsuchiya, Karen D. "Fluorescence In Situ Hybridization." Clinics in Laboratory Medicine 31, no. 4 (2011): 525–42. http://dx.doi.org/10.1016/j.cll.2011.08.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Nederlof, P. M., S. van der Flier, J. Wiegant, et al. "Multiple fluorescence in situ hybridization." Cytometry 11, no. 1 (1990): 126–31. http://dx.doi.org/10.1002/cyto.990110115.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Stanley, P. E., and L. J. Kricka. "Fluorescence in situ hybridization: 1998." Luminescence 14, no. 4 (1999): 221–30. http://dx.doi.org/10.1002/(sici)1522-7243(199907/08)14:4<221::aid-bio546>3.0.co;2-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Yalcin, Ozben, and Gamze Kulduk. "Fluorescence in Situ Hybridization in Pathology." European Archives of Medical Research 34, Suppl 1 (2018): 46–47. http://dx.doi.org/10.5152/eamr.2018.81300.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Raap, Anton K. "Advances in fluorescence in situ hybridization." Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 400, no. 1-2 (1998): 287–98. http://dx.doi.org/10.1016/s0027-5107(98)00029-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Milosevic, Ivana, Stevan Popovic, and Ivana Urosevic. "Fluorescence in situ hybridization in hematology." Vojnosanitetski pregled 69, no. 11 (2012): 986–93. http://dx.doi.org/10.2298/vsp1211986m.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

ANASTASI, JOHN. "Fluorescence in Situ Hybridization in Leukemia." Annals of the New York Academy of Sciences 677, no. 1 Clinical Flow (1993): 214–24. http://dx.doi.org/10.1111/j.1749-6632.1993.tb38779.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Wang, Changning, Daniela C. Popescu, Chunying Wu, Junqing Zhu, Wendy Macklin, and Yanming Wang. "In Situ Fluorescence Imaging of Myelination." Journal of Histochemistry & Cytochemistry 58, no. 7 (2010): 611–21. http://dx.doi.org/10.1369/jhc.2010.954842.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Edwards, A. A. "Editorial - Fluorescence In Situ Hybridisation (FISH)." Radiation Protection Dosimetry 88, no. 1 (2000): 5–6. http://dx.doi.org/10.1093/oxfordjournals.rpd.a033019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Onozato, Maristela L., Clarence Yapp, Douglas Richardson, et al. "Highly Multiplexed Fluorescence in Situ Hybridization for in Situ Genomics." Journal of Molecular Diagnostics 21, no. 3 (2019): 390–407. http://dx.doi.org/10.1016/j.jmoldx.2019.01.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Cherin, P., M. Cl Crevon, J. J. Hauw, P. Galanaud, S. Herson, and D. Emilie. "Etude des cellules cytotoxiques par hybridation in situ et immunohistochimie dans les biopsies musculaires de polymyosites et dermatomyosites." La Revue de Médecine Interne 14, no. 6 (1993): 493. http://dx.doi.org/10.1016/s0248-8663(05)80427-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Gozzetti, Alessandro, and Michelle M. Le Beau. "Fluorescence in situ hybridization: Uses and limitations." Seminars in Hematology 37, no. 4 (2000): 320–33. http://dx.doi.org/10.1016/s0037-1963(00)90013-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Tkachuk, D. C., D. Pinkel, W. L. Kuo, H. U. Weier, and J. W. Gray. "Clinical applications of fluorescence in situ hybridization." Genetic Analysis: Biomolecular Engineering 8, no. 2 (1991): 67–74. http://dx.doi.org/10.1016/1050-3862(91)90051-r.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Bertaux, J., U. Gloger, M. Schmid, A. Hartmann, and S. Scheu. "Routine fluorescence in situ hybridization in soil." Journal of Microbiological Methods 69, no. 3 (2007): 451–60. http://dx.doi.org/10.1016/j.mimet.2007.02.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

YOSHIDA, MICHIHIRO C. "Recent Advances in Fluorescence in situ Hybridization." Journal of Radiation Research 33, SUPPLEMENT (1992): 54–60. http://dx.doi.org/10.1269/jrr.33.supplement_54.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

He, Rong, Anne E. Wiktor, Curtis A. Hanson, et al. "Conventional Karyotyping and Fluorescence In Situ Hybridization." American Journal of Clinical Pathology 143, no. 6 (2015): 873–78. http://dx.doi.org/10.1309/ajcpp6lvmqg4lnck.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Ferrara, Gerardo, and Anna Chiara De Vanna. "Fluorescence In Situ Hybridization for Melanoma Diagnosis." American Journal of Dermatopathology 38, no. 4 (2016): 253–69. http://dx.doi.org/10.1097/dad.0000000000000380.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Torok, O., I. Zsupan, Zs Buezico, R. Adany, and M. Balazs. "Fluorescence in situ hybridization on uncultured amniocytes." International Journal of Gynecology & Obstetrics 70 (2000): D142. http://dx.doi.org/10.1016/s0020-7292(00)84665-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Chen, Robert F. "In situ fluorescence measurements in coastal waters." Organic Geochemistry 30, no. 6 (1999): 397–409. http://dx.doi.org/10.1016/s0146-6380(99)00025-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Wang, Chang-Liang, Wen-Hua Zhao, Jinming Yu, and Sheng Li. "Fluorescence In Situ Hybridization Analysis of Pancreatoblastoma." Pancreas 38, no. 2 (2009): 224–26. http://dx.doi.org/10.1097/mpa.0b013e318172b8f8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Gozzetti, Alessandro, and Michelle M. Le Beau. "Fluorescence in situ hybridization: Uses and limitations." Seminars in Hematology 37, no. 4 (2000): 320–33. http://dx.doi.org/10.1053/shem.2000.16443.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Bryant, Stewart. "Medicare funding for fluorescence in situ hybridisation." Pathology 39, no. 5 (2007): 535. http://dx.doi.org/10.1080/00313020701621369.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Swiger, Roy R., and James D. Tucker. "Fluorescence in situ hybridization: A brief review." Environmental and Molecular Mutagenesis 27, no. 4 (1996): 245–54. http://dx.doi.org/10.1002/(sici)1098-2280(1996)27:4<245::aid-em1>3.0.co;2-c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

AMANN, Rudolf. "Methodological Aspects of Fluorescence In Situ Hybridization." Bioscience and Microflora 19, no. 2 (2000): 85–91. http://dx.doi.org/10.12938/bifidus1996.19.85.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Montilla, F., and R. Mallavia. "In situ Electrochemical Fluorescence Studies of PPV." Journal of Physical Chemistry B 110, no. 51 (2006): 25791–96. http://dx.doi.org/10.1021/jp065070s.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

SERWER, PHILIP, SHIRLEY J. HAYES, KAREN LIEMAN, and GARY A. GRIESS. "In situ fluorescence microscopy of bacteriophage aggregates." Journal of Microscopy 228, no. 3 (2007): 309–21. http://dx.doi.org/10.1111/j.1365-2818.2007.01855.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Hyytinen, E., P. Hurskainen, T. Visakorpi, et al. "Methodological development of fluorescence in situ hybridization." Cancer Genetics and Cytogenetics 77, no. 2 (1994): 164. http://dx.doi.org/10.1016/0165-4608(94)90292-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Lerner, Boaz. "Bayesian fluorescence in situ hybridisation signal classification." Artificial Intelligence in Medicine 30, no. 3 (2004): 301–16. http://dx.doi.org/10.1016/j.artmed.2003.11.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Halling, Kevin C., and Benjamin R. Kipp. "Fluorescence in situ hybridization in diagnostic cytology." Human Pathology 38, no. 8 (2007): 1137–44. http://dx.doi.org/10.1016/j.humpath.2007.04.015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Reardon, Kenneth F., Thomas Scheper, and James E. Bailey. "In situ fluorescence monitoring of immobilizedClostridium acetobutylicum." Biotechnology Letters 8, no. 11 (1986): 817–22. http://dx.doi.org/10.1007/bf01020831.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!